Fig. 5 | Scientific Reports

Fig. 5

From: Prognostic impact of extracellular volume fraction derived from equilibrium contrast-enhanced CT in HCC patients receiving immune checkpoint inhibitors

Fig. 5

Forest plot of subgroup analysis of overall survival between Lower tumor ECV and Higher tumor ECV groups. The dashed line indicates a risk ratio of 1. ECV extracellular volume, HBV hepatitis B virus, ICIs immune checkpoint inhibitors, TKIs tyrosine kinase inhibitors, PVTT portal vein tumor thrombosis, BCLC stage Barcelona clinic liver cancer stage, ECOG PS eastern cooperative oncology group physical status, AFP alpha-fetoprotein.

Back to article page